A Multicenter, Randomized, Open Label, Parallel Group, Active Control Study to Evaluate the Efficacy and Safety of LNG IUS (Mirena(R)) as Compared to Medroxyprogesterone Acetate During 6 Cycles of Treatment in Patients With Idiopathic Menorrhagia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Levonorgestrel (Primary) ; Medroxyprogesterone
- Indications Menorrhagia
- Focus Registrational; Therapeutic Use
- 09 Dec 2013 Biomarkers information updated
- 15 Sep 2010 Additional location (Argentina) identified as reported by ClinicalTrials.gov.
- 15 Sep 2010 Additional location (Argentina) identified as reported by ClinicalTrials.gov.